Loading FOR…
Loading financial statements…
Import this data to Google Sheets with:
=jivedata("FOR","financials")Full statements spill as a table. For one cell: =jivedata("FOR","Revenue") or =jivedata("FOR","Revenue","TTM"). Install the Jive Data add-on, then paste into a cell.
FOR • CIK 0001406587
| (in thousands, except per share data) | FY 2023 | FY 2024 | FY 2025 | TTM |
|---|---|---|---|---|
| Revenues | $1,436,900 | $1,509,400 | $1,662,400 | $1,724,800 |
| Cost of Goods and Services Sold | $1,132,800 | $1,150,100 | $1,298,900 | $1,355,900 |
| Selling, General and Administrative Expense | $97,700 | $118,500 | $154,400 | $155,200 |
| Income (Loss) from Equity Method Investments | $0 | $0 | $600 | $0 |
| Gain (Loss) on Disposition of Assets | $1,600 | $9,500 | $4,500 | $4,500 |
| Interest and Other Income | $13,600 | $19,800 | $6,300 | $8,500 |
| Gain (Loss) on Repurchase of Debt Instrument | — | — | $-1,200 | $-100 |
| Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest | $221,600 | $270,100 | $219,300 | $226,600 |
| Income Tax Expense (Benefit) | $54,700 | $66,700 | $51,400 | $56,000 |
| Net Income (Loss) Attributable to Parent | $166,900 | $203,400 | $167,900 | $170,400 |
| Weighted Average Number of Shares Outstanding, Basic | 49,986,526 | 50,426,040 | 50,872,335 | 51,059,739 |
| Weighted Average Number of Shares Outstanding, Diluted | 50,124,113 | 50,793,954 | 51,059,852 | 51,227,853 |
| Incremental Common Shares Attributable to Dilutive Effect of Conversion of Preferred Stock | 137,587 | 367,914 | 187,517 | 187,517 |
| (in thousands, except per share data) | FY 2023 | FY 2024 | FY 2025 | TTM |
|---|---|---|---|---|
| Cash and Cash Equivalents, at Carrying Value | $616,000 | $481,200 | $379,200 | $394,900 |
| Inventory, Real Estate, Land and Land Development Costs | $1,790,300 | $2,266,200 | $2,645,100 | $2,711,500 |
| Equity Method Investments | $500 | $300 | $0 | $0 |
| Property, Plant and Equipment, Net | $5,900 | $7,100 | $8,100 | $7,300 |
| Liabilities and Equity | $2,470,700 | $2,840,100 | $3,137,000 | $3,220,600 |
| Other Assets | $58,000 | $85,300 | $104,600 | $106,900 |
| Accounts Payable | $68,400 | $85,900 | $71,000 | $65,300 |
| Contract with Customer, Liability | $121,400 | $172,300 | $193,300 | $202,200 |
| Deferred Income Tax Liabilities, Net | $50,700 | $67,500 | $86,200 | $92,800 |
| Accrued Liabilities | $61,200 | $68,300 | $83,100 | $88,600 |
| Long-term Debt | $695,000 | $706,400 | $802,700 | $793,800 |
| Liabilities | $1,100,800 | $1,245,000 | $1,368,100 | $1,362,800 |
| Stockholders' Equity Attributable to Noncontrolling Interest | $1,000 | $1,000 | $1,000 | $1,200 |
| Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest | $1,369,900 | $1,595,100 | $1,768,900 | $1,857,800 |
| Common Stock, Value, Issued | $49,900 | $50,700 | $50,800 | $51,000 |
| Additional Paid in Capital, Common Stock | $644,200 | $665,200 | $671,000 | $676,100 |
| Retained Earnings (Accumulated Deficit) | $674,800 | $878,200 | $1,046,100 | $1,129,500 |
| Stockholders' Equity Attributable to Parent | $1,368,900 | $1,594,100 | $1,767,900 | $1,856,600 |
| Common Stock, Shares Authorized | 200,000,000 | 200,000,000 | 200,000,000 | 200,000,000 |
| Common Stock, Shares, Issued | 49,903,713 | 50,653,637 | 50,833,171 | 51,008,733 |
| (in thousands, except per share data) | FY 2023 | FY 2024 | FY 2025 | TTM |
|---|---|---|---|---|
| Net Income (Loss) Attributable to Parent | $166,900 | $203,400 | $167,900 | $170,400 |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect | $351,200 | $-134,800 | $-102,000 | $205,700 |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents | $616,000 | $481,200 | $379,200 | $458,900 |
| Notes Issued | $0 | $9,900 | $0 | $0 |
| Income Taxes Paid, Net | $44,700 | $45,700 | $30,800 | $30,800 |
| Depreciation, Depletion and Amortization | $3,000 | $3,000 | $3,500 | $3,200 |
| Payments to Acquire Property, Plant, and Equipment | $1,300 | $2,200 | $2,200 | $1,000 |
| Increase (Decrease) in Deferred Income Taxes | $-13,800 | $-16,800 | $-18,700 | $-14,900 |
| Proceeds from Equity Method Investment, Distribution, Return of Capital | $0 | $0 | $900 | $0 |
| Income (Loss) from Equity Method Investments | $0 | $0 | $600 | $0 |
| Proceeds from Sales of Assets, Investing Activities | $1,600 | $9,500 | $4,500 | $4,500 |
| Share-based Payment Arrangement, Noncash Expense | $4,300 | $5,300 | $7,300 | $8,400 |
| Net Cash Provided by (Used in) Investing Activities | $300 | $7,300 | $3,200 | $3,500 |
| Production Related Impairments or Charges | $24,000 | $4,100 | $7,200 | $11,300 |
| Gain (Loss) on Repurchase of Debt Instrument | — | — | $-1,200 | $-100 |
| Net Cash Provided by (Used in) Operating Activities | $364,100 | $-158,400 | $-197,700 | $283,900 |
| Proceeds from Issuance of Common Stock | $0 | $19,700 | $0 | $0 |
| Proceeds from Issuance of Debt | — | — | $780,000 | $0 |
| Repayments of Debt | — | — | $680,000 | $80,500 |
| Payments of Financing Costs | $0 | — | $6,200 | $-100 |
| Payment, Tax Withholding, Share-based Payment Arrangement | $700 | $3,400 | $1,800 | $2,100 |
| Proceeds, Issuance of Shares, Share-based Payment Arrangement, Excluding Option Exercised | — | — | $500 | $800 |
| Net Cash Provided by (Used in) Financing Activities | $-13,200 | $16,300 | $92,500 | $-81,700 |
| Increase (Decrease) in Inventories | $-206,300 | $469,900 | $384,800 | $-106,900 |
| Increase (Decrease) in Other Operating Assets | $7,000 | $27,700 | $7,400 | $-12,700 |
| Increase (Decrease) in Accounts Payable and Accrued Liabilities | $-12,700 | $24,700 | $-14,400 | $-3,300 |
| Increase (Decrease) in Accrued Liabilities and Other Operating Liabilities | $-18,200 | $40,500 | $-12,800 | $-9,000 |
| Increase (Decrease) in Contract with Customer, Liability | $-14,700 | $50,900 | $21,000 | $-27,400 |